Related Experiment Videos
Melatonin protects LDL from oxidation but does not prevent the apolipoprotein derivatization
1Gerontological Research Department of I.N.R.C.A. Ancona, Italy. C.Pieri@INCRA.IT
Biochemical and Biophysical Research Communications
|May 15, 1996
Summary
Melatonin protects low-density lipoprotein (LDL) lipids from copper-induced peroxidation in vitro. However, melatonin oxidation by-products may modify apolipoprotein B, potentially promoting LDL atherogenicity.
Area of Science:
- Biochemistry
- Oxidative Stress Research
- Lipid Metabolism
Background:
- Low-density lipoprotein (LDL) peroxidation is a key factor in atherosclerosis.
- Melatonin is a potent antioxidant with radical scavenging properties.
- Understanding LDL modification is crucial for cardiovascular disease research.
Purpose of the Study:
- To investigate the in vitro protective effect of melatonin against copper-induced LDL peroxidation.
- To determine if melatonin or its oxidation by-products affect apolipoprotein B.
Main Methods:
- In vitro study using low-density lipoprotein (LDL).
- Copper (Cu++) induction of LDL peroxidation.
- Diene formation kinetic analysis.
- Analysis of apolipoprotein B (apo-B) derivatization using fluorescence, electrophoretic mobility, and lysine residue analysis.
- Macrophage uptake assays.
Main Results:
- Melatonin prolonged lag time and delayed peak time of diene formation, indicating protection of LDL lipids.
- Apolipoprotein B (apo-B) in melatonin-treated LDL showed signs of derivatization.
- Melatonin-treated LDL exhibited properties similar to oxidized LDL, including increased macrophage uptake.
Conclusions:
- Melatonin protects LDL lipids from Cu++ induced peroxidation.
- Oxidation by-products of melatonin may derivatize apo-B, leading to an atherogenic LDL form.
- Further research is needed to elucidate the implications of melatonin-induced apo-B modification in atherogenesis.